Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      Home/Our innovation /Focus areas/Oncology/A less invasive solution
      Scientist working in a lab in Cork

      A less invasive solution

      Beating bladder cancer for good

      Share Article
      Share to

      Every day, doctors have their work cut out for them. They’re constantly bombarded with new clinical data, product information and innovation. And through it all, they’re tasked with delivering outstanding care for the ones they serve.

      As partners in care, we asked ourselves how we could turn something overwhelming into an advantage. And Medical Engagement.ai was born, created to blend de-identified patient-level healthcare data into tangible and predictive insights that have real impact on patients.

      Medical Engagement.ai is a first-in-industry effort built in partnership with data and advanced analytics teams to turn real world data and clinical input into a measure of “unmet medical need”: proactively and predictively identifying patients who aren’t benefitting from the most effective treatments for their specific disease, or who may be lagging behind the latest recommended guidelines. In the U.S. alone, we’ve started to identify medical unmet needs in 7 different disease areas, engaged with more than 5,000 additional HCPs, and identified approximately 75,000 patients with one or more unmet medical needs that can be addressed through partnership with customers.

      The AI and advanced analytic algorithms enables our Medical Science Liaisons to partner with physicians, nurses, and institutions to determine which patients can benefit from appropriate treatments (as recommended by the latest clinical guidelines). It allows us to predict which approved clinical and product information would help our customers address those unmet needs — and connect them with this information when they need it.

      As our discoveries lead to more data generation, we’re creating a feedback loop that helps us better understand the diseases we focus on, their genetic components, medicines that perform especially well with specific patient subpopulations, and greater foresight into the endpoints we may want to focus on for clinical trials.

      Working together with medical providers and the people they serve, we can not only help change individual lives — but create a healthier world.

      Latest oncology news